The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study

The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study

This study assesses the synergistic effect of the combination of cephalosporins and sulbactam with daptomycin against daptomycin-nonsusceptible, vancomycin-intermediate resistant <i>Staphylococcus aureus</i> (VISA) or heterogeneous vancomycin-intermediate <i>S. aureus</i> (h-...

Full description

Bibliographic Details
Main Authors:	Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Tsuey-Pin Lin, Hung-Jui Chen, Bo-An Su, Chien-Ming Chao, Yin-Ching Chuang, Hung-Jen Tang
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Antibiotics
Subjects:	vancomycin-intermediate resistant <i>s. aureus</i> heterogeneous vancomycin-intermediate <i>s. aureus</i> daptomycin cephalosporin sulbactam synergism test
Online Access:	https://www.mdpi.com/2079-6382/8/4/184

Similar Items

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01)

Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis
by: Alberto Enrico Maraolo, et al.
Published: (2021-08-01)

Adaptive Laboratory Evolution of <i>Staphylococcus aureus</i> Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance
by: Vladimir Gostev, et al.
Published: (2023-05-01)

Epidemiology of <i>Staphylococcus aureus</i> Non-Susceptible to Vancomycin in South Asia
by: Mohammad Ejaz, et al.
Published: (2023-05-01)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant <i>Staphylococcus</i> <i>aureus</i> with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
by: Masaru Samura, et al.
Published: (2022-03-01)

Real-World Clinical Characteristics and Outcomes with Daptomycin Use in Pediatric Patients: A Retrospective Case Series
by: Hanna Persha, et al.
Published: (2024-09-01)

Vancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment
by: Xuhui Zhu, et al.
Published: (2015-04-01)

Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia
by: Kazuhiro Ishikawa, et al.
Published: (2022-02-01)

Catalase Protects Biofilm of <i>Staphylococcus aureus</i> against Daptomycin Activity
by: Cristina El Haj, et al.
Published: (2021-04-01)

Daptomycin versus Glycopeptides for the Treatment of <i>Enterococcus faecium</i> Bacteraemia: A Cohort Study
by: Daniel Echeverría-Esnal, et al.
Published: (2021-06-01)

Genomic Insights into <i>Staphylococcus aureus</i> Isolates Exhibiting Diminished Daptomycin Susceptibility
by: Natalia Gómez-Casanova, et al.
Published: (2024-02-01)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
by: Rafael San-Juan, et al.
Published: (2016-06-01)

A <i>Kayvirus</i> Distant Homolog of Staphylococcal Virulence Determinants and VISA Biomarker Is a Phage Lytic Enzyme
by: Aleksandra Głowacka-Rutkowska, et al.
Published: (2020-03-01)

Niosomal tannic acid drug delivery system: An efficient strategy against vancomycin-intermediate Staphylococcus aureus (VISA) infections
by: Jaber Hemmati, et al.
Published: (2024-07-01)

The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant <i>Staphylococcus aureus</i>
by: Md Saruar Bhuiyan, et al.
Published: (2021-01-01)

Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
by: Jennifer M. Sim, et al.
Published: (2016-02-01)

The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022-12-01)

The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study
by: Tai-Chung Tseng, et al.
Published: (2023-01-01)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
by: Taylor Morrisette, et al.
Published: (2020-10-01)

Data Mining Models in Prediction of Vancomycin-Intermediate <i>Staphylococcus aureus</i> in Methicillin-Resistant <i>S. aureus</i> (MRSA) Bacteremia Patients in a Clinical Care Setting
by: Wei-Chuan Chen, et al.
Published: (2025-01-01)

İnvestigation of Daptomycin Sensitivities in Methicillin Resistant Staphylococcus Aureus and Vancomycin Resistant Enterococcal Strains by İn Vitro E-Test Method
by: Nuray Arı, et al.
Published: (2021-10-01)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
by: Tong J, et al.
Published: (2021-07-01)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
by: Hideo Kato, et al.
Published: (2022-05-01)

Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis
by: Takumi Umemura, et al.
Published: (2024-04-01)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
by: Weiwei Li, et al.
Published: (2022-06-01)

In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against <i>Staphylococcus aureus</i>
by: Patricia Esteban, et al.
Published: (2021-01-01)

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
by: Feng-Jui Chen, et al.
Published: (2018-05-01)

Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus
by: Parviz Mohajeri, et al.
Published: (2014-12-01)

Genotyping of methicillin resistant staphylococcus aureus from tertiary care hospitals in Coimbatore, South India
by: Toms John Peedikayil Neetu, et al.
Published: (2016-01-01)

Vancomycin Intermediate MRSA Isolates Obtained from Retail Chicken Meat and Eggs Collected at Pokhara, Nepal
by: Surya Prasad Devkota, et al.
Published: (2019-12-01)

A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
by: Jann-Tay Wang, et al.
Published: (2022-10-01)

In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
by: Wei Yu, et al.
Published: (2020-09-01)

Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline
by: Omar Ahmad, et al.
Published: (2019-11-01)

Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
by: Michelle Su, et al.
Published: (2021-07-01)

Determination of Vancomycin Minimum Inhibitory Concentration in Methicillinresistant Staphylococcus aureus by Various Phenotypic Methods: A Cross-sectional Study
by: Jyoti Sangwan, et al.
Published: (2024-04-01)

Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
by: Qiwen Hu, et al.
Published: (2016-10-01)

A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus
by: Jiade Zhu, et al.
Published: (2021-02-01)

Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
by: Celia Permuy, et al.
Published: (2023-06-01)

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
by: Shuguang Li, et al.
Published: (2017-11-01)

Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection
by: Yu-Jui Chang, et al.
Published: (2017-11-01)